Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells.

Ordonez P, Kunzelmann S, Groom HC, Yap MW, Weising S, Meier C, Bishop KN, Taylor IA, Stoye JP.

Sci Rep. 2017 Feb 21;7:42824. doi: 10.1038/srep42824.

2.

Expression levels of Fv1: effects on retroviral restriction specificities.

Li W, Yap MW, Voss V, Stoye JP.

Retrovirology. 2016 Jun 24;13(1):42. doi: 10.1186/s12977-016-0276-7.

3.

Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice.

Goldstone DC, Walker PA, Calder LJ, Coombs PJ, Kirkpatrick J, Ball NJ, Hilditch L, Yap MW, Rosenthal PB, Stoye JP, Taylor IA.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9609-14. doi: 10.1073/pnas.1402448111. Epub 2014 Jun 16.

4.

Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.

Yap MW, Colbeck E, Ellis SA, Stoye JP.

PLoS Pathog. 2014 Mar 6;10(3):e1003968. doi: 10.1371/journal.ppat.1003968. eCollection 2014 Mar.

5.

Apparent effect of rabbit endogenous lentivirus type K acquisition on retrovirus restriction by lagomorph Trim5αs.

Yap MW, Stoye JP.

Philos Trans R Soc Lond B Biol Sci. 2013 Aug 12;368(1626):20120498. doi: 10.1098/rstb.2012.0498. Print 2013 Sep 19.

6.

A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.

Goldstone DC, Flower TG, Ball NJ, Sanz-Ramos M, Yap MW, Ogrodowicz RW, Stanke N, Reh J, Lindemann D, Stoye JP, Taylor IA.

PLoS Pathog. 2013 May;9(5):e1003376. doi: 10.1371/journal.ppat.1003376. Epub 2013 May 9.

7.

Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.

Ohkura S, Goldstone DC, Yap MW, Holden-Dye K, Taylor IA, Stoye JP.

PLoS Pathog. 2011 Mar;7(3):e1002011. doi: 10.1371/journal.ppat.1002011. Epub 2011 Mar 31.

8.

Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

Groom HC, Yap MW, Galão RP, Neil SJ, Bishop KN.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5166-71. doi: 10.1073/pnas.0913650107. Epub 2010 Mar 1.

9.

Restriction of foamy viruses by primate Trim5alpha.

Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, Hanenberg H, Ohkura S, Stoye JP.

J Virol. 2008 Jun;82(11):5429-39. doi: 10.1128/JVI.02462-07. Epub 2008 Mar 26.

10.

Chance favors a prepared genome.

Stoye JP, Yap MW.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3177-8. doi: 10.1073/pnas.0800667105. Epub 2008 Feb 25. No abstract available.

11.

TRIM5 alpha cytoplasmic bodies are highly dynamic structures.

Campbell EM, Dodding MP, Yap MW, Wu X, Gallois-Montbrun S, Malim MH, Stoye JP, Hope TJ.

Mol Biol Cell. 2007 Jun;18(6):2102-11. Epub 2007 Mar 28.

12.
13.

Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1.

Bishop KN, Mortuza GB, Howell S, Yap MW, Stoye JP, Taylor IA.

J Virol. 2006 Aug;80(16):8225-35.

15.

Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.

Dodding MP, Bock M, Yap MW, Stoye JP.

J Virol. 2005 Aug;79(16):10571-7.

16.

Retroviral capsid determinants of Fv1 NB and NR tropism.

Stevens A, Bock M, Ellis S, LeTissier P, Bishop KN, Yap MW, Taylor W, Stoye JP.

J Virol. 2004 Sep;78(18):9592-8.

17.

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Nisole S, Lynch C, Stoye JP, Yap MW.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13324-8. Epub 2004 Aug 23.

18.

Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Yap MW, Nisole S, Lynch C, Stoye JP.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91. Epub 2004 Jul 12.

19.

Bending out and breaking away: host-cell accomplices in retroviral escape.

Yap MW, Stoye JP.

J Biol. 2003;3(1):3. Epub 2003 Dec 19. Review.

Supplemental Content

Loading ...
Support Center